Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Compass Group upgrades FY profit guidance, acquires Dutch food services business

(Sharecast News) - Food services business Compass Group upgraded FY25 profit guidance on Tuesday on the back of strong organic growth and a better-than-expected M&A performance. Compass said it had delivered "another strong performance" in Q3, with organic revenues growing 8.6% in the quarter and 8.5% for the year to date. Both regions performed well, with North America delivering "strong growth" across all sectors.

The FTSE 100-listed group said net new business growth continued in the middle of its 4-5% target range, supported by strong client retention of over 96%.

Volume growth in both regions was also said to have "remained positive", with North America particularly strong as it benefited from favourable hospitality events. Growth in its international division was "slightly lower compared to Q2", due to mobilisation timings.

"We are pleased with our third quarter performance with continued strong organic revenue growth and M&A performing better than expected," said Compass.

"As a result, we are upgrading our 2025 guidance. We now expect constant currency underlying operating profit growth to be towards 11%, driven by organic revenue growth above 8% and ongoing margin progression."

Compass Group also announced it has agreed to acquire Vermaat Groep, a leading premium food services business in Europe, for approximately €1.5bn. Compass noted that Vermaat was a market leader in the Netherlands, with a growing presence in Germany and France, all of which were among the firm's top ten markets.

Vermaat was said to be on track to generate sales of roughly €700.0m in FY25, with a double-digit operating margin. In the first full year of ownership, Vermaat was expected to be margin and EPS accretive to Compass.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.